Cambridge Investment Research Advisors’s Aceragen Inc ACGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-636	Closed	-$4K	–	3287
2022 Q4	$4K	Buy	+636	New	+$3.81K	﹤0.01%	3091
2018 Q3	–	Sell	-132	Closed	-$24K	–	2320
2018 Q2	$24K	Hold	132	–	–	﹤0.01%	2186
2018 Q1	$33K	Hold	132	–	–	﹤0.01%	2116
2017 Q4	$38K	Hold	132	–	–	﹤0.01%	2076
2017 Q3	$40K	Hold	132	–	–	﹤0.01%	1963
2017 Q2	$31K	Hold	132	–	–	﹤0.01%	1901
2017 Q1	$44K	Hold	132	–	–	﹤0.01%	1734
2016 Q4	$27K	Hold	132	–	–	﹤0.01%	1641
2016 Q3	$46K	Hold	132	–	–	﹤0.01%	1703
2016 Q2	$28K	Sell	132 -30	-19%	-$6.61K	﹤0.01%	1530
2016 Q1	$44K	Buy	162 +15	+10%	+$4.01K	﹤0.01%	1560
2015 Q4	$62K	Hold	147	–	–	﹤0.01%	1522
2015 Q3	$67K	Hold	147	–	–	﹤0.01%	1376
2015 Q2	$74K	Hold	147	–	–	﹤0.01%	1384
2015 Q1	$74K	Hold	147	–	–	﹤0.01%	1356
2014 Q4	$88K	Sell	147 -37	-20%	-$14.8K	﹤0.01%	1300
2014 Q3	$57K	Hold	184	–	–	﹤0.01%	1422
2014 Q2	$73K	Buy	184 +22	+14%	+$9.07K	﹤0.01%	1299
2014 Q1	$90K	Buy	162 +30	+23%	+$20.5K	﹤0.01%	1245
2013 Q4	$83K	Buy	+132	New	+$44K	﹤0.01%	1188

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Cambridge Investment Research Advisors's ACGN Position: Q1 2023 in Review

Cambridge Investment Research Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 636 shares — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in ACGN in Q4 2013 and held it in 20 quarters. The position peaked at $90K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

Cambridge Investment Research Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
Cambridge Investment Research Advisors sold 636 Aceragen Inc shares in Q1 2023, an estimated $4K.
Cambridge Investment Research Advisors first reported a position in Aceragen Inc in Q4 2013 and held it in 20 quarters.
Cambridge Investment Research Advisors's Aceragen Inc position peaked at $90K in Q1 2014.
19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.